export const SEED_POLICIES = [
  {
    policy_id: "P001",
    name: "Home & Community-Based Services (HCBS)",
    description: "Medicaid waiver programs providing personal care, respite, home modifications and other services as alternatives to institutional care. State-administered with federal matching.",
    convergence_score: 6,
    qualities: ["V1", "V2", "V4", "V5", "V6", "V8"],
    risk_level: "critical",
  },
  {
    policy_id: "P002",
    name: "Program of All-Inclusive Care for the Elderly (PACE)",
    description: "Capitated managed care model for dual-eligible individuals 55+ who qualify for nursing facility care. PACE organizations receive fixed monthly payments and provide all needed services.",
    convergence_score: 5,
    qualities: ["V2", "V4", "V5", "V6", "V7"],
    risk_level: "critical",
  },
  {
    policy_id: "P003",
    name: "Acute Hospital Care at Home (AHCAH)",
    description: "CMS waiver program allowing hospitals to provide acute-level care in patient homes. Removed geographic and facility requirements for qualifying conditions.",
    convergence_score: 5,
    qualities: ["V1", "V3", "V4", "V5", "V6"],
    risk_level: "critical",
  },
  {
    policy_id: "P004",
    name: "ACO Realizing Equity, Access, and Community Health (ACO REACH)",
    description: "Global capitation model for accountable care organizations. Organizations take on full financial risk for assigned Medicare beneficiaries.",
    convergence_score: 4,
    qualities: ["V2", "V4", "V6", "V7"],
    risk_level: "high",
  },
  {
    policy_id: "P005",
    name: "340B Drug Pricing Program",
    description: "Federal program requiring drug manufacturers to sell outpatient drugs at discounted prices to eligible healthcare organizations serving low-income patients. No cap on spread.",
    convergence_score: 4,
    qualities: ["V2", "V6", "V7", "V8"],
    risk_level: "high",
  },
  {
    policy_id: "P006",
    name: "MA Special Supplemental Benefits for the Chronically Ill (SSBCI)",
    description: "Medicare Advantage plans can offer non-primarily health-related supplemental benefits to chronically ill enrollees. Benefits determined by plan with limited CMS oversight.",
    convergence_score: 3,
    qualities: ["V2", "V3", "V4"],
    risk_level: "medium",
  },
  {
    policy_id: "P007",
    name: "IRA Medicare Drug Negotiation (MFP)",
    description: "New program under Inflation Reduction Act for CMS to negotiate prices for high-spend Medicare drugs. First negotiated prices effective 2026.",
    convergence_score: 2,
    qualities: ["V3", "V6"],
    risk_level: "low",
  },
];

export const CONVERGENCE_THRESHOLD = 3;
